Q3 2024 Chemours Co Earnings Call Transcript
Key Points
- The Chemours Co (CC) reported a 21% year-over-year increase in Opteon refrigerant sales, reflecting strong demand and market adoption.
- The company achieved a record sales figure for its TSS business in the third quarter, driven by robust growth in Opteon refrigerants.
- The TT business exceeded its year-to-date savings target, achieving $130 million in savings, surpassing the $125 million goal.
- Chemours has successfully remediated two of its four material weaknesses, showing progress in addressing control issues.
- The company outlined a refreshed corporate strategy, 'Pathway to Thrive,' focusing on operational excellence, growth, portfolio management, and long-term strengthening.
- The Chemours Co (CC) reported a net loss of $27 million for the third quarter, including a $56 million non-cash impairment charge.
- Advanced Materials results were weaker than anticipated due to pricing conditions and a softer market environment.
- The APM segment's adjusted EBITDA decreased by 43%, with a significant decline in EBITDA margin.
- Freon refrigerant pricing pressures continue due to elevated HFC inventory levels in the United States.
- The company anticipates a sequential decline in net sales and adjusted EBITDA for the fourth quarter due to typical seasonal trends.
Good morning. My name is Daniel and I will be your conference operator today. I would like to welcome everyone to the Chemours company third-quarter 2024 results conference call. Currently all participants are in listen-only mode. A question and answer session will follow the conclusion of the prepared remarks. I would like to remind everyone that this conference call is being recorded.
I would now like to hand the conference call over to Brandon Ontjes, Vice President of Investor Relations for Chemours. You may begin your conference.
Good morning, everybody. Welcome to The Chemours company's third-quarter 2024 earnings conference Call. I'm joined today by Denise Dignam, Chemours' President and Chief Executive Officer; and our Chief Financial Officer, Shane Hostetter.
Before we start, I would like to remind you that comments made on this call as well as in the supplemental information provided on our website contain forward-looking statements and involve risks and uncertainties as described
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |